Wave Life Sciences
110 hedge funds and large institutions have $316M invested in Wave Life Sciences in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 10 closing their positions.
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
44% more call options, than puts
Call options by funds: $4.2M | Put options by funds: $2.91M
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
21% more funds holding
Funds holding: 91 → 110 (+19)
3% more capital invested
Capital invested by funds: $306M → $316M (+$9.49M)
0.03% more ownership
Funds ownership: 82.35% → 82.38% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$27.4M |
| 2 |
Primecap Management
Pasadena,
California
|
+$21.8M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$11.7M |
| 4 |
LM
Luminus Management
Houston,
Texas
|
+$9.82M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$24.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.98M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$2.76M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.01M |
WVE Hedge Fund Activity: Q3 2020 in Review
110 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2020, worth a combined $316M — up 3.1% from $306M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new WVE positions and 10 closed out — a net gain of 19 holders — while 43 added to existing stakes and 30 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $27.4M. The largest seller was RTW Investments, exiting entirely with an estimated $24.9M sold.
- 110 institutional investors held Wave Life Sciences (WVE) as of Q3 2020, up from 91 in Q2 2020.
- Funds reported $316M of Wave Life Sciences stock for Q3 2020, up 3.1% quarter-over-quarter.
- 29 funds opened new Wave Life Sciences positions in Q3 2020 and 10 closed out, a net change of +19 holders.
- The largest Wave Life Sciences buyer in Q3 2020 was Perceptive Advisors, an estimated $27.4M added.
- The largest Wave Life Sciences seller in Q3 2020 was RTW Investments, an estimated $24.9M sold.
Based on aggregated 13F filings for Q3 2020.